Financial Results Presentation for the Second Quarter of the Fiscal Year Ending March 2027
Results presentationFirst half, FY ending Mar 2027Published 2026-11-16 15:30
In the second quarter of the fiscal year ending March 2027, revenue and all profit measures exceeded the year-earlier period, reaching record highs both for the cumulative period and the quarter alone. The full-year forecast is unchanged. Secondary care is ahead of plan, while home care has experienced inventory shortages and delays in launching new products.
In short
Forecast unchanged
Revenue and all profit measures exceeded the year-earlier period, reaching record highs both cumulatively and for the quarter alone.
Secondary care exceeded plan, while some of the inventory shortage in home care was resolved, although the launch of new products was postponed to April 2027.
The company will expand into Nagoya and Fukuoka, strengthen the capacity to accept patients at Tokyo Hospital and Kawasaki Main Hospital, and invest in a new electronic medical records system and AI and data platforms.
What they reported
this period against the same period a year earlier, and where they now expect the year to end
Sales
¥3.4bn+11.0%vs a year earlier
H1 FY26¥3.0bnH1 FY27¥3.4bn
Sales by quarter
Period
¥bn
FY25 Q1
1.3
FY25 Q2
1.3
FY25 Q3
1.4
FY25 Q4
1.3
FY26 Q1
1.5
FY26 Q2
1.6
FY26 Q3
1.6
FY26 Q4
1.5
FY27 Q1
1.6
last year 6.2was 6.6now 6.6
Full-year forecast, ¥bn±0.0% vs the old forecast
Forecast from this deck (no earlier forecast on record)
Why
The number of consultations in secondary care remained solid, diagnostic imaging cases increased slightly, and stronger sales initiatives also proved effective in home care.
二次診療:診療数が堅調に推移。画像診断サービス:診断件数は微増。在宅ケア:営業強化策が奏功し好調。
Secondary care: The number of consultations remained solid. Diagnostic imaging services: The number of diagnostic cases increased slightly. Home care: Stronger sales initiatives proved effective, resulting in solid performance.
Bright spot
Quarterly revenue and cumulative revenue for the second quarter reached record highs.
四半期売上高は過去最高。Q2累計実績としても売上高・各利益で過去最高を更新(3期連続)
Quarterly revenue reached a record high. Cumulative second-quarter revenue and all profit measures also reached record highs, marking the third consecutive period.
Operating profit
¥0.7bn+22.7%vs a year earlier
H1 FY26¥0.6bnH1 FY27¥0.7bn
Operating profit by quarter
Period
¥bn
FY25 Q1
0.1
FY25 Q2
0.2
FY25 Q3
0.2
FY25 Q4
0.1
FY26 Q1
0.3
FY26 Q2
0.3
FY26 Q3
0.4
FY26 Q4
0.2
FY27 Q1
0.3
last year 1.2was 1.3now 1.3
Full-year forecast, ¥bn±0.0% vs the old forecast
Forecast from this deck (no earlier forecast on record)
Why
In addition to the effect of higher revenue, the previous fiscal year's price revisions and productivity improvements boosted profits.
各利益:増収効果に加え、前年度に実施した価格改定効果や継続的な生産性向上の取り組み等が寄与。
All profit measures: In addition to the effect of higher revenue, the effects of the price revisions implemented in the previous fiscal year and ongoing productivity improvement initiatives, among other factors, contributed.
Ordinary profit
¥0.7bn+21.1%vs a year earlier
H1 FY26¥0.6bnH1 FY27¥0.7bn
Ordinary profit by quarter
Period
¥bn
FY25 Q1
0.2
FY25 Q2
0.2
FY25 Q3
0.2
FY25 Q4
0.1
FY26 Q1
0.3
FY26 Q2
0.3
FY26 Q3
0.4
FY26 Q4
0.2
FY27 Q1
0.3
last year 1.1now 1.2
Full-year forecast, ¥bnthe first forecast for this year
Forecast from this deck (no earlier forecast on record)
Why
The effect of higher revenue, price revisions, and productivity improvement initiatives, among other factors, contributed to all profit measures.
各利益:増収効果に加え、前年度に実施した価格改定効果や継続的な生産性向上の取り組み等が寄与。
All profit measures: In addition to the effect of higher revenue, the effects of the price revisions implemented in the previous fiscal year and ongoing productivity improvement initiatives, among other factors, contributed.
Net profit
¥489.0m+18.4%vs a year earlier
H1 FY26¥413.0mH1 FY27¥489.0m
Net profit by quarter
Period
¥m
FY25 Q1
103.0
FY25 Q2
139.0
FY25 Q3
167.0
FY25 Q4
111.0
FY26 Q1
180.0
FY26 Q2
233.0
FY26 Q3
262.0
FY26 Q4
158.0
FY27 Q1
239.0
last year 833.0was 890.0now 890.0
Full-year forecast, ¥m±0.0% vs the old forecast
Forecast from this deck (no earlier forecast on record)
Why
The effect of higher revenue, price revisions, and productivity improvement initiatives, among other factors, contributed to all profit measures.
各利益:増収効果に加え、前年度に実施した価格改定効果や継続的な生産性向上の取り組み等が寄与。
All profit measures: In addition to the effect of higher revenue, the effects of the price revisions implemented in the previous fiscal year and ongoing productivity improvement initiatives, among other factors, contributed.
Their own numbers
figures this company chose to report, a year ago against now
Number of initial consultations
5,978 transactions · a year ago 5,519 transactions
The cumulative number of initial consultations in the second quarter was 5,978, representing progress of 51.5% against the full-year plan.
a year agonow3,000 transactions8,000 transactions
Number of initial consultations
11,604 transactionsFY27 plan · FY26 10,953 transactions
The full-year plan calls for 11,604 initial consultations.
The number of affiliated hospitals increased by 126 from the year-earlier period, bringing the affiliated hospital ratio to 37.1%.
now3,000 facilities6,000 facilities
Affiliated hospital ratio
37.1 %
The affiliated hospital ratio rose to 37.1%.
now20 %50 %
Number of veterinarians providing secondary care
107 people
The number of veterinarians in secondary care increased by 7 from the end of the previous fiscal year.
now50 people200 people
EBITDA+11.0%
¥1.0bn · a year ago ¥0.9bn
EBITDA increased 11.0% year on year.
a year agonow¥0.5bn¥1.5bn
The low–high ranges are Komori's estimate, not figures the company gave.
Everything else in the deck
What moved
change vs a year earlier, by the company's own breakdown
Operating income
Revenue growth+¥333.0m
Personnel expenses−¥145.0m
Facilities and IT−¥61.0m
Depreciation and amortization+¥43.0m
Other−¥35.0m
Bar colour is the direction of the amount (red = up, teal = down).
New initiatives
what they said they're starting
The company will acquire the land and buildings adjacent to Tokyo Hospital and strengthen the patient-acceptance capacity of Tokyo Hospital and Kawasaki Main Hospital.
Construction is scheduled to begin in April 2027 for the renovation of Nagoya Hospital.
A next-generation electronic medical records system with enhanced security will be brought into operation in stages from autumn 2027.
The company will consider developing services including AI diagnostic imaging, AI-assisted medical care, and AI-powered automatic entry into electronic medical records.
The company will deploy an integrated CRM across the group and promote joint sales activities.
JARMeC Care Tech will proceed with demonstrations of new products and automated vital-sign monitoring.
What decks usually leave out
COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deck
Margins and overheads
where each ¥100 of sales goes
Computed
a year ago¥19.5 profit per ¥100
60.1
20.4
19.5
now¥21.5 profit per ¥100
57.2
21.3
21.5
Cost of making itOverheads (selling, admin)Operating profit
Gross margin
39.9% → 42.8%+2.9 pts
Operating margin
19.5% → 21.5%+2.0 pts
Overheads (selling and admin costs): ¥714.0m
Financial targets
the last five years against the target (green band), where one is stated
Computed
Return on equity18.5%
profit earned on shareholders' money
14% or higher
in the target zone
Return on equity
Period
%
FY22
11.8
FY23
12.2
FY24
9.0
FY25
13.1
FY26
18.5
Equity ratio43.1%
how much of the balance sheet is owned outright
−4.3 pts on last year
Equity ratio
Period
%
FY22
36.0
FY23
43.2
FY24
43.5
FY25
47.4
FY26
43.1
Payout ratio18.9%
share of profit paid as dividends
−0.7 pts on last year
Payout ratio
Period
%
FY22
0.0
FY23
0.0
FY24
16.0
FY25
19.4
FY26
19.6
FY27
18.9
Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.
How they rate themselves against plan
the company's own grade for the period, next to the numbers
What they said
Above plan
Revenue and all profit measures have been tracking above expectations, and secondary care is ahead of plan.
売上高・各利益は想定を上回って推移。
• 二次診療は計画を上回って推移、画像診断はほぼ計画どおり。
Revenue and all profit measures have been tracking above expectations.
• Secondary care has been tracking ahead of plan, while diagnostic imaging has been broadly in line with plan.
Mid-term plan targets
Medium-term management plan · to 2027
Hospital revenueFinal year¥4.9bn
Consolidated net salesFinal year¥6.6bn
Consolidated operating profitFinal year¥1.3bn
ROEFinal year17%
Store or site count
Number of hospitals
4
there a year agonew this yearlost
Market size and share
square area = market size · a year ago outlined, now filled
Affiliated hospital ratio among companion-animal veterinary clinics
The number of affiliated hospitals was 4,842.
their share
36.6% → 37.1%
+0.50 pts
The company's slice (blue) is drawn magnified so a small share stays visible; compare it with its own dashed outline from a year ago.
Not mentioned in this deck
10
By businessCapital spendingShare buybackDividendForecast assumptionsRisks priced into the forecastOrders and backlogPrice and volumeHeadcountInvestor Q&A
Financial Results Presentation for the Second Quarter of the Fiscal Year Ending March 2027 | Japan Animal Referral Medical Center Co.,Ltd. (6039) timely disclosure | Komori